Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Radius Health

Explore full profile

Global biopharmaceutical company focused on addressing unmet medical needs in the area of bone health

Cambridge, United StatesFounded 2003Biotech & Life Sciences
Valuation $890M Market cap · 2022
Revenue $243M Latest reported FY
Total funding $100–500M Disclosed equity funding

About Radius Health

Radius Health, Inc. is a fully integrated biopharmaceutical company focused on developing and commercializing innovative endocrine therapeutics. The company primarily serves patients suffering from osteoporosis and breast cancer, aiming to address significant unmet medical needs in these areas. Operating in the healthcare and pharmaceutical markets, Radius Health employs a business model that spans from drug discovery and development to commercialization. Revenue is generated through the sale of its FDA-approved products, as well as through strategic partnerships and collaborations with other pharmaceutical companies. The company's flagship product, abaloparatide, is a treatment for osteoporosis, and it continues to advance its pipeline with new therapeutic candidates. Radius Health is committed to scientific excellence and improving patient outcomes through its innovative therapies.

Source: Dealroom company data

At a glance

Founded
2003
Headquarters
Cambridge, United States
Listing
IPO 2014
Sector
Biotech & Life Sciences
Power Law
Thoroughbred$100M+ revenue

Latest news

Press, funding announcements and product moves mentioning Radius Health.

See all news

Investors

15 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A6 investors entered at this stage

  • MPM BioImpact
  • HealthCare Ventures
  • Wellcome Trust
  • Oxford Bioscience Partners
  • Scottish Widows
  • BB Biotech Ventures

Series B and later9 investors entered at this stage

  • MPM Bio IV NVS Strategic Fund
  • Scottish Widows Investment Partnership
  • Nordic Bioscience
  • Brookside Capital
  • Saints Capital
  • Ipsen Pharma SA
  • Biotech Growth
  • Gurnet Point Capital
  • Patient Square Capital

Talent

Book a demo to see the people
Team profiled 21 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
2 countries with
team presence
🇺🇸 United States99.1%
🇮🇳 India0.5%
2 countries shown
Web traffic by country
9K monthly visits
across markets
🇺🇸 United States97.8%
🇮🇳 India3.3%
Top 2 markets shown

Patents

Estimated portfolio value
$76M

44 active patent families included in this estimate.

A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.

Explore the patent portfolioPatent records, technology areas and peer comparisonsBook a demo

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Radius Health on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Radius Health on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles